Cargando…
A case of VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) with decreased oxidative stress levels after oral prednisone and tocilizumab treatment
VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome has recently been described as an autoinflammatory disease associated with severe adult-onset inflammatory manifestations. The various clinical manifestations include recurrent high-grade fever, neutrophilic dermatoses, cutane...
Autores principales: | Tozaki, Nagie, Tawada, Chisato, Niwa, Hirofumi, Mizutani, Yoko, Shu, En, Kawase, Aki, Miwa, Yuki, Ohnishi, Hidenori, Sasai, Hideo, Miyako, Keisuke, Hosokawa, Junichi, Kato, Ayaka, Kobayashi, Kazuhiro, Miyazaki, Tatsuhiko, Shirakami, Yohei, Shimizu, Masahito, Iwata, Hiroaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760706/ https://www.ncbi.nlm.nih.gov/pubmed/36544501 http://dx.doi.org/10.3389/fmed.2022.1046820 |
Ejemplares similares
-
Tocilizumab for treatment of cutaneous and systemic manifestations of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome without myelodysplastic syndrome
por: Goyal, Amrita, et al.
Publicado: (2022) -
Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome—clinical presentation of a newly described somatic, autoinflammatory syndrome
por: Alhomida, Faris, et al.
Publicado: (2021) -
Innovations in genomics for undiagnosed diseases: vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome
por: Stubbins, Ryan J., et al.
Publicado: (2022) -
Pulmonary manifestations in VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome: a systematic review
por: Kouranloo, Koushan, et al.
Publicado: (2023) -
Quantitative Assessment of Vacuolization of Myeloid Precursors in VEXAS Syndrome
por: Rabut, Audrey, et al.
Publicado: (2023)